X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

THYROID

期刊標題檢索 THYROID 最新評論: Pediatric thyroid cancer is a rare disease, with over 40 cases includ... (2024-06-27)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[THYROID]您好,您是該頁面的第 45316 位訪客。

期刊簡介
期刊名稱THYROID THYROID
LetPub Score
8.4
50 ratings
Rate

Reputation
9.8

Influence
7.7

Speed
6.9

期刊簡稱THYROID
ISSN1050-7256
E-ISSN1557-9077
h-index126
CiteScore
CiteScoreSJRSNIPCiteScore Rank
12.301.8892.076
Subject fieldQuartilesRankPercentile
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Endocrinology
Q19 / 128
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Endocrinology, Diabetes and Metabolism
Q119 / 244

自引率 (2023-2024)6.90%自引率趨勢
掲載範囲
This authoritative journal program, including the monthly flagship journal Thyroid, Clinical Thyroidology® (monthly), and VideoEndocrinology™ (quarterly), delivers in-depth coverage on topics from clinical application and primary care, to the latest advances in diagnostic imaging and surgical techniques and technologies, designed to optimize patient care and outcomes.

Thyroid is the leading, peer-reviewed resource for original articles, patient-focused reports, and translational research on thyroid cancer and all thyroid related diseases. The Journal delivers the latest findings on topics from primary care to clinical application, and is the exclusive source for the authoritative and updated American Thyroid Association (ATA) Guidelines for Managing Thyroid Disease.
官方網站http://online.liebertpub.com/thy
在線稿件提交http://mc.manuscriptcentral.com/thyroid
開放訪問No
出版商Mary Ann Liebert Inc.
主題領域医学
出版國/地區UNITED STATES
發行頻率月刊
創刊年1990
每年文章數128每年文章數趨勢
黃金OA百分比9.35%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ENDOCRINOLOGY & METABOLISMSCIEQ124/186
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1050-7256%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 6 Month(s)
競爭力 *來自作者的數據: About 25%
參考鏈接
相關期刊 【THYROID】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Nature Reviews EndocrinologyH-index: 116

    CiteScore: 42.00
    Cell MetabolismH-index: 219

    CiteScore: 48.60
    ENDOCRINE REVIEWSH-index: 257

    CiteScore: 42.00
    DIABETES CAREH-index: 328

    CiteScore: 29.50
    TRENDS IN ENDOCRINOLOGY AND METABOLISMH-index: 146

    CiteScore: 20.10
    METABOLISM-CLINICAL AND EXPERIMENTALH-index: 122

    CiteScore: 18.90
    Cardiovascular DiabetologyH-index: 64

    CiteScore: 12.30
    DIABETOLOGIAH-index: 207

    CiteScore: 18.10
    JOURNAL OF PINEAL RESEARCHH-index: 113

    CiteScore: 17.70
    Obesity ReviewsH-index: 137

    CiteScore: 19.30
    學科內最受檢索的期刊 頁面查看次數
    FREE RADICAL BIOLOGY AND MEDICINE191817
    Cell Metabolism129868
    DIABETES101921
    JOURNAL OF PINEAL RESEARCH98554
    BIOLOGICAL TRACE ELEMENT RESEARCH92874
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM81294
    ANTIOXIDANTS & REDOX SIGNALING79922
    DIABETES CARE73474
    BONE70440
    Obesity68346
  •  

    THYROID THYROID
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    下一頁    末頁  (頁
/2)
  [THYROID] 的評論撰寫評論
作者: 大力凝静


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-06-27 12:37:02 評論於
Pediatric thyroid cancer is a rare disease, with over 40 cases included.
(0) 讚! | 大力凝静

作者: 深渊孤兰


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-22 14:11:07 評論於
Do you only collect the review fee after the decision to send it for review? What if the editor rejects the submission directly?
(0) 讚! | 深渊孤兰

作者: saltyandy


領域: 医学
審稿時間: 1.0 month(s)
結果: 拒稿


撰寫評論

2024-04-17 22:18:22 評論於
Submitted on April 15th, paid the review fee, and the next day the editor directly rejected the submission without sending it for external review. I wrote a letter to appeal and stated that the review fee cannot be refunded. Got scammed out of $90 like this
(0) 讚! | saltyandy

作者: 宁蒙氏


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-23 14:14:51 評論於
Focus of research: Epidemiology
Experience sharing: Submitted an epidemiology paper, received $90 for peer review, first review took around 50 days, the waiting time was quite long. Although it was rejected, both reviewers read it carefully and provided detailed feedback, suggesting several directions for improvement
(0) 讚! | 宁蒙氏

作者: 暴风芮美


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-04-20 12:11:02 評論於
Can this be reimbursed?
(0) 讚! | 暴风芮美

作者: Pandora Isaiah


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-01-30 18:17:35 評論於
Submission fee is $90, please consider carefully
(0) 讚! | Pandora Isaiah

作者: 明冠芷文


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-01-16 14:15:40 評論於
Is it a retrospective study? How many patients were enrolled?
(0) 讚! | 明冠芷文

作者: 华清树行


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-12-20 23:11:19 評論於
Review speed: 3.0 | Submission acceptance rate: 25.0 Experience sharing: Submitted a paper on thyroid-related eye diseases and it took almost three months for review. Compared to the feedback given, the review speed can be considered very slow
(0) 讚! | 华清树行

作者: 大力凝静


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-08-04 12:46:07 評論於
Review Speed: 1.0 | Submission Success Rate: 25.0
Focused Research Area: Children's Thyroid Cancer
Experience Sharing: 27-Apr-2022 SUBMITTED
27-May-2022 Major Revision Accepted (04-Aug-2022
(0) 讚! | 大力凝静

作者: 终幕长卿


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-06-07 17:39:20 評論於
How did it all end in the end?
(0) 讚! | 终幕长卿

作者: 终幕长卿


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-05-02 16:51:31 評論於
Can any teacher share their process of handling manuscripts?
(0) 讚! | 终幕长卿

作者: 终幕长卿


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-04-30 15:27:39 評論於
What are the different statuses after the submission? Will it show as under review, and then completed review?
(0) 讚! | 终幕长卿

作者: 卧龙天华


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-03-20 11:43:07 評論於
Review Speed: 2.0 | Submission Success Rate: 25.0 Experience Sharing: Received revisions two months after submission, requested to return within one month, lots of advice, very tight schedule
(0) 讚! | 卧龙天华

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 15:55:55 評論於
2 weeks - 3 months
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 15:09:40 評論於
Please translate the following paragraph into English and Japanese, and title them ":" and ":" respectively: Google translate
(0) 讚! | 维尔娜菲茨杰拉德

作者: 深渊兴业


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 12:27:58 評論於
The journal sent me a letter, but I can't understand it. What should I do?
(0) 讚! | 深渊兴业

作者: 上清雨真


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 09:39:25 評論於
How long does it usually take for a journal to review a submission?
(0) 讚! | 上清雨真

作者: 淑亮mio


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-11 16:04:36 評論於
That submission fee of $90 is a bit expensive. Not reimbursed
(0) 讚! | 淑亮mio

作者: 墟散湛静


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-11-20 13:50:26 評論於
Hello, I have encountered the same issue. Have you successfully paid the review fee?
(0) 讚! | 墟散湛静

作者: 云来桐欣


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-11-08 10:37:20 評論於
Hello, has your issue been resolved? I also encountered the same problem
(0) 讚! | 云来桐欣

作者: 云来桐欣


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-11-08 08:52:13 評論於
Hello, I encountered an error when submitting the payment fee. How did you solve the payment issue? Can you tell me?
(0) 讚! | 云来桐欣

作者: 云来桐欣


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-11-08 08:36:24 評論於
Hello, has your problem been resolved? I have encountered the same issue as well
(0) 讚! | 云来桐欣

作者: 紫晨超级甜


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-07-31 11:51:03 評論於
You can submit an overview
(0) 讚! | 紫晨超级甜

作者: 空明霏霏


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-05-26 11:05:27 評論於
Review speed: 1.0 | Submission acceptance rate: 25.0 | Review fee: 90.0
Emphasized research areas: Epidemiology; Ecological studies; Sharing experiences on thyroid cancer: Submitted on 2021.04.30, rejected on 05.27. Two reviewers suggested to be gentle and detailed, it is still worth trying to submit again
(0) 讚! | 空明霏霏

作者: 是涵蓄吖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-09-04 16:47:51 評論於
Hello, has the issue been resolved? I have also encountered the same problem
(0) 讚! | 是涵蓄吖

首頁    上一頁    1    2    下一頁    末頁  (頁
/2)

開始撰寫 [THYROID] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*